glp-1 for iih Recurrent Idiopathic Intracranial Hypertension–Related Papilledema After Abrupt Discontinuation of Semaglutide: JNO Article: https://bit.ly/JNO_recurr_IIH_GLP1RA #brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology #Medicine #Papilledema GLP-1 medications and pseudotumor cerebri
Description
Antihypertensive effects of SGLT2-i, which have been reported in clinical trials, are presumably due to their natriuretic effect
Advanced Appetite Control & Craving Reduction
Womens Health Outcomes In Aons study, GLP1 users experienced a 37 percent reduction in hospitalizations caused by MACE (including stroke, heart attack and heart failure) over the 24 months following GLP-1 therapy initiation
Johnson ML, Saffrey MJ, Taylor VJ
FDA program
An update on global epidemiology in heart failure
